The largest database of trusted experimental protocols

2 protocols using vuf5574

1

Adenosine Receptor Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco’s Modified Eagle’s Medium (DMEM), Roswell Park Memorial Institute 1640 medium (RPMI 1640), fetal bovine serum (FBS), penicillin–streptomycin, and glutamine were purchased from Gibco (Thermo Fisher, Germany). Trypsin-EDTA solution, adenosine, inosine, AMP, ADP, and ATP, the A2b (alloxazine) and A3 adenosine receptors (VUF5574), and caffeine, a non-selective adenosine antagonist, were purchased from Sigma-Aldrich (Germany). The antagonists for A1 (DPCPX) and A2a (SCH-58261) adenosine receptors were purchased from Tocris, UK.
+ Open protocol
+ Expand
2

Adenosine Receptor Antagonist Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four different ligands for specific ARs were tested in this study, including a
selective adenosine A1 receptor (A1R)-specific antagonist
[8-cyclopentyl-1,3-dipropyl xanthine] DPCPX (Sigma, USA, named DPCPXA1R below), a selective adenosine A2A receptor (A2AR)-specific antagonist
[4-(2-[7-amino-2-(2-furyl)[1,2,4]-triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)-phenol]
ZM241385 (Sigma, USA, named ZMA2AR below), a selective adenosine A2B receptor (A2BR)-specific antagonist
[N-(4-cyanophenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-
phenoxy]acetamide] MRS1754 (Sigma, USA, named MRSA2BR below), and a selective adenosine A3 receptor (A3R)-specific antagonist
[N-(2-methoxyphenyl)-N′ -[2-(3-pyridinyl)-4-quinazolinyl]-urea] VUF5574 (Sigma,
USA, named VUFA3R below). All reagents were dissolved in 25% dimethylsulfoxide (DMSO)
solution. All other chemicals and solvents were from standard commercial sources
and were of analytical or pharmaceutical grade.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!